Nikolaos Papanikolaou's profile picture

Nikolaos Papanikolaou

Principal Investigator In Oncologic Imaging, Head Of Computational Clinical Imaging Group at Champalimaud Foundation

Nikolaos Papanikolaou, Ph.D. has a diverse work experience in the field of oncologic imaging and machine learning imaging. Nikolaos currently serves as the Principal Investigator in Oncologic Imaging and the Head of the Computational Clinical Imaging Group at the Champalimaud Foundation. Nikolaos also holds the position of Honorary Reader at The Institute of Cancer Research and is the Machine Learning Imaging Lead at The Royal Marsden NHS Foundation Trust. Additionally, they are an Affiliated Researcher at ICS-FORTH and a Section Editor for Cancer Imaging. Prior to their current roles, they were a Visiting Researcher at Karolinska Institutet and the owner of MRIcons. Nikolaos also served as the MR Excellence Program Scientific Director at Affidea. Earlier in their career, they worked as a Research Associate at the University Hospital of Heraklion and as an MRI Applications Consultant at Siemens Healthcare.

Nikolaos Papanikolaou, Ph.D. has a diverse education history in the field of healthcare and artificial intelligence. In 1987, they obtained a B.Sc. in Biomedical Engineering from Technologiko Ekpaideutiko Idrima, Athinas. Later, they pursued further studies and completed their Ph.D. in Medical School at the University of Crete from 2004 to 2007.

In 2013, Nikolaos earned a Diploma in Enterprise and Entrepreneurship from the London School of Business and Finance. Nikolaos continued their education in the field of Artificial Intelligence in Healthcare, obtaining a Certificate from the MIT Sloan School of Management in 2020.

In addition to their formal education, Nikolaos holds various certifications to enhance their expertise. Nikolaos received certifications such as the Crash Course in Causality: Inferring Causal Effects from Observational Data from the University of Pennsylvania in 2023, Four Rare Machine Learning Skills All Data Scientists Need from SAS in 2023, and Evaluations of AI Applications in Healthcare from Stanford University in 2023. Nikolaos also obtained certifications from prestigious institutions such as John Hopkins University, DeepLearning.AI, Amazon Web Services (AWS), LinkedIn, and IBM.

Overall, Nikolaos Papanikolaou, Ph.D. has demonstrated a commitment to continuous learning and has acquired a diverse range of qualifications to expand their knowledge and skills in healthcare and artificial intelligence.

Location

Lisbon, Portugal

Links

Previous companies


Org chart


Teams


Offices


C

Champalimaud Foundation

The mission of the Champalimaud Foundation is to develop programmes of advanced biomedical research and provide clinical care of excellence, with a focus on translating pioneering scientific discoveries into solutions which can improve the quality of life of individuals around the world. This is done with independence, rigour, dedication, creativity and with a commitment to meet the highest ethical and scientific standards. By its actions the Foundation strives to be a world leader in scientific and technological innovation with the ultimate objective of preventing, diagnosing and treating disease. In so doing, the Foundation is guided by the constant challenge of finding new solutions to humanity’s most pressing health problems.


Headquarters

Lisbon, Portugal

Employees

501-1,000

Links